Authors
Latest:
Herpes Viruses May Fuel the Development of Alzheimer DiseaseRecent research investigated how HSV-1 infection affects tau phosphorylation through the cGAS-STING-TBK1 pathway, highlighting potential new therapeutic strategies for Alzheimer disease.
Latest:
Dyskinesia and Patient Communication in Parkinson DiseasePanelists discuss how early recognition of dyskinesia symptoms, ongoing patient-clinician communication, and individualized treatment strategies are key to effectively managing Parkinson disease and improving patients’ quality of life.
Latest:
Stanford Children’s Health: A Comprehensive Approach to Care for a Child With a Neurological ConditionPhysicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.
Latest:
Roundtable: The Future of Stereotactic and Functional NeurosurgeryTwo experts at Jefferson Health discuss several topics related to advances in neurosurgery, technology, and the future of minimally invasive procedures.
Latest:
Future of Treating DMDFinal thoughts from leading experts on the future of treating Duchenne muscular dystrophy and keeping standard of care in the forefront.
Latest:
Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhalThe expert panel shares clinical pearls for treatment and management of Spinal Muscular Atrophy. O painel de especialistas compartilha recomendações valiosas para o tratamento e manejo da atrofia muscular espinhal.
Latest:
Holistic Care and Advanced Technology Integration for Neurologic Disease Management: Donald Whiting, MDThe chair of Allegheny Health Network’s Neurosciences Institute talked about its comprehensive center that integrates multidisciplinary resources and technology to provide quality care for patients with chronic neurologic conditions. [WATCH TIME: 5 minutes]
Latest:
Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhDThe postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]
Latest:
Advancing the Treatment of Pediatric Migraine With Nerivio REN Wearable: Klaus Werner, MD & Alon IroniThe pediatric neurologist at Duke Health and chief executive officer at Theranica talked about a remote electrical neuromodulation wearable that showed promising results for the treatment and prevention of migraine in pediatric patients. [WATCH TIME: 5 minutes]
Latest:
Expanding Care Horizons in Pediatric Sleep Disorder Management: Adam S. Rappoport, MDThe director of sleep medicine at Nemours Children's Health in Florida talked about the growing treatment landscape for pediatric sleep disorders and the vital role of family-centered, multidisciplinary care. [WATCH TIME: 5 minutes]
Latest:
Taking the Leap: Forging Your Own Path as a Woman in MedicineTheresa Sevilis, DO, writes on picking a career path in medicine as a woman, and how deciding to jump ship from a traditional path was among the best decisions she's made.
Latest:
AUPN Leadership Minute Episode 16: Turning Your Clinic Into a Source of Scholarly ActivityEpisode 16 of the AUPN Leadership Minute features Rohit Das, MD, of UT Southwestern Medical Center; and Selim R. Benbadis, MD, FAAN, FACNS, FAES, University of South Florida Morsani College of Medicine. [WATCH TIME: 4 minutes]
Latest:
Lessons in Migraine Medicine and Changes to the Treatment Toolbox: Stephen Samples, MDThe chair of Allegheny Health Network’s department of neurology provided insight on his clinical experiences with migraine medicine and how the field needs to adapt to the ongoing changes to treatment options. [WATCH TIME: 4 minutes]
Latest:
Neurologist’s Role in Addressing Healthcare Disparities: A. Gordon Smith, MD, FAANThe professor and chair of neurology at Virginia Commonwealth University discussed how neurologists are urged to take organized action and provide training on healthcare disparities, with a particular focus on race, ethnicity, and financial barriers to access. [WATCH TIME: 2 minutes]
Latest:
Role of Fluid Biomarkers and GFAP in Neurodegeneration: Charles Bernick, MDThe neurologist at Cleveland Clinic provided perspective on the reasons to study individuals exposed to repetitive head impacts and the lessons learned about monitoring glial fibrillary acidic protein over time. [WATCH TIME: 4 minutes]
Latest:
PPD/TFS Fostering Global Awareness in Rare DisordersRare Disease Day raises awareness for rare disorders, highlighting challenges, improving detection, and fostering collaboration for treatment advancements.
Latest:
Maximizing Exercise as Movement Medicine for Neuromuscular Diseases: Donovan Lott, PT, PhD, CSCSThe research associate professor in the department of physical therapy at the University of Florida talked about physical therapy inventions for neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 4 minutes]
Latest:
New Horizons in Multiple SclerosisExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
2022 SMA Research & Clinical Care Meeting: What to ExpectMary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.
Latest:
Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older AdultsFalls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.
Latest:
The Future of Parkinson Disease Treatment With Innovative Wearable Devices: Alistair Mackett, MDThe movement disorder specialist at Cambridge University Hospitals NHS Foundation Trust discussed the rise of wearable technology for managing Parkinson disease to potentially empower patients and monitor the disease at early stages. [WATCH TIME: 4 minutes]
Latest:
Shifting to a Collaborative Approach to Conquer Challenges in Progressive MS: Anne H. Cross, MDThe professor of neurology at Washington University School of Medicine discussed the growing sense of hope among patients with progressive multiple sclerosis as providers gain an understanding in treating this form of the disease. [WATCH TIME: 3 minutes]
Latest:
TSC Alliance’s Growth Has Led to Improved Lives and Progress Toward a CureIn light of Tuberous Sclerosis Complex (TSC) Awareness Month throughout May, Kari Rosbeck, president and CEO, TSC Alliance, highlights what has been done to advance TSC research and how the organization is improving the diagnosis journey, access to care, and support for families.
Latest:
Epilepsy Awareness and First Aid for Seizures in 2024: Claude Steriade, MD, CMThe epileptologist at NYU Langone Health and associate professor of neurology at NYU Grossman School of Medicine talked about the ongoing need to improve public awareness and education on seizure first aid. [WATCH TIME: 3 minutes]
Latest:
Future Plans, Goals for Prime PD: Konstantin Karmazin, MDThe chief medical officer of Prime PD, a new digital wellness studio for patients with Parkinson disease, detailed future initiatives for the platform. [WATCH TIME: 4 minutes]
Latest:
The Evolutionary Arch of Stereoelectroencephalography in the United StatesSEEG has transformed the surgical investigation of refractory epilepsy, enabling clinicians to map complex seizure networks with precision, leading to more targeted treatment options for patients.
Latest:
Recommendations for Treating Epilepsy in the Clinical Space: Christopher Elder, MDThe clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health gives recommendations for clinical care on prescribed antiseizure medication and RNA therapy. [WATCH TIME: 5 minutes]
Latest:
Assessing Potential Treatment Options for Agitation in Older Adults With Alzheimer Disease: George Grossberg, MDThe director of Geriatric Psychiatry at the St Louis University School of Medicine talked about BXCL501 as a potential treatment for acute agitation in patients with Alzheimer disease and how it compares with brexpiprazole, the first approved therapy. [WATCH TIME: 4 minutes]
